Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple m (Q60203634)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 August 2010

Language	Label	Description	Also known as
English	Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple m	scientific article published on 23 August 2010

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Joaquin Martinez-Lopez

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Norma C. Gutiérrez

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Josep-Maria Ribera

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Ramón García-Sanz

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

María-Belén Vidriales

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

María Victoria Mateos

1

object named as

María-Victoria Mateos

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Juan José Lahuerta

27

object named as

Juan-José Lahuerta

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Joaquín Díaz-Mediavilla

10

object named as

Joaquín Díaz Mediavilla

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

15

object named as

Ana Sureda

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

17

object named as

Joan Bargay

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Felipe de Arriba

12

object named as

Felipe de Arriba

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

José García-Laraña

7

object named as

José García-Laraña

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

28

object named as

Joan Bladé

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

25

object named as

Bruno Paiva

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Ana-Isabel Teruel

5

object named as

Ana-Isabel Teruel

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Maria Teresa Cibeira

22

object named as

María-Teresa Cibeira

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Enrique García Bengoechea

8

object named as

Enrique Bengoechea

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jose Luis Bueso Bello

16

object named as

José-Luis Bello

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

María Luisa Mateos-Martín

20

object named as

María-Luisa Martín-Mateos

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

María-Luisa Martín-Ramos

23

object named as

María-Luisa Martín Ramos

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

María-Angeles Montalbán

26

object named as

María-Angeles Montalbán

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jesús San Miguel

29

object named as

Jesús-Fernando San Miguel

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Raquel de Paz

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Alejandro Martín

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Luis Palomera

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Yolanda González

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jose-Mariano Hernández

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Francisco-Javier Peñalver

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

23 August 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

934-941

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cox regression methods for two-stage randomization designs.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-stage randomization designs in drug development

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hazard Rate Models with Covariates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970187-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(10)70187-X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739218%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q60203634&oldid=2015702186"